Ad is loading...

SABS SAB Biotherapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

SABS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SABS
(Try 14 days for Free)

View a ticker or compare two or three

Compare

SABS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SABS
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

SABS is expected to report earnings to fall 16.67% to -83 cents per share on March 28

SAB Biotherapeutics SABS Stock Earnings Reports

Q4'23

Est.

$-0.83

Q3'23

Missed

by $0.88

Q2'23

Missed

by $1.26

Q1'23

Missed

by $1.39

Q4'22

Missed

by $1.71

The last earnings report on November 14 showed earnings per share of -100 cents, missing the estimate of -11 cents. With 84.88K shares outstanding, the current market capitalization sits at 28.61M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2100 East 54th Street North

Phone

+1 605 679-6980

Employees

Web

https://www.sabbiotherapeutics.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
AOMR	9.80	-0.06	-0.61%
Angel Oak Mortgage REIT
TEX	51.98	-0.59	-1.12%
Terex Corp
FCUV	0.23	-0.01	-3.31%
Focus Universal
CCEP	75.76	-3.01	-3.82%
Coca-Cola Europacific Partners plc
GYRE	13.12	-0.72	-5.20%
Gyre Therapeutics

SABS and Stocks

Correlation & Price change

A.I.dvisor tells us that SABS and HOOK have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SABS and HOOK's prices will move in lockstep.

Ticker / NAME	Correlation To SABS	1D Price Change %
SABS	100%	-16.22%
HOOK - SABS	30% Poorly correlated	-4.46%
RLAY - SABS	27% Poorly correlated	-8.84%
ATNF - SABS	25% Poorly correlated	-6.72%
NKTX - SABS	25% Poorly correlated	-6.30%
JAGX - SABS	24% Poorly correlated	-7.69%
More